News - Sanofi

Filter

Current filters:

Sanofi

Popular Filters

126 to 150 of 304 results

Generics take toll on Sanofi's 1st-qtr sales, with net profit down 33.5%

02-05-2013

French drug major Sanofi (Euronext: SAN) today (May 2) reported first-quarter 2013 financial results…

BiotechnologyFinancialGenzymePharmaceuticalSanofi

Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer

28-04-2013

The US District Court for the Central District of California issued a ruling recently in an unusual,…

AmphastarGenericsLegalLovenoxNorth AmericaPharmaceuticalPricingSanofi

Sanofi's Aubagio delayed onset of clinically definite MS in TOPIC study

25-04-2013

French drug major Sanofi (Euronext: SAN) US biotech subsidiary Genzyme announced today positive top-line…

AubagioBiotechnologyGenzymeNeurologicalPharmaceuticalResearchSanofi

Sanofi says pediatric vaccine Hexyon/Hexacima approved in Europe

22-04-2013

The European Commission has approved French drug major Sanofi (Euronext: SAN) subsidiary Sanofi Pasteur's…

EuropeHexacimaHexyonMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

Sanofi and PATH launch large-scale production of semi-synthetic artemisinin in Italy

12-04-2013

French drug major Sanofi (Euronext: SAN) and non-profit global health organization PATH's Drug Development…

artemisininPharmaceuticalProductionSanofiTropical diseases

Sanofi Pasteur MSD files for EU approval of "Quadrivalent" flu vaccine

11-04-2013

Sanofi Pasteur MSD, the joint venture between French drug major Sanofi (Euronext: SAN) vaccines unit…

EuropeMerck & CoPharmaceuticalRegulationSanofiSanofi PasteurSanofi Pasteur MSDVaccines

Merrimack presents encouraging preclinical research with MM-121 in ER-positive breast cancer model

11-04-2013

USA-based Merrimack Pharmaceuticals (Nasdaq: MACK) has announced preclinical study results showing that…

Merrimack PharmaceuticalsMM-121OncologyPharmaceuticalResearchSanofi

Sanofi broadens collaboration with Pieris

10-04-2013

German independent, clinical-stage biotech firm Pieris AG and French drug major Sanofi (Euronext|: SAN)…

LicensingPharmaceuticalPieris AGResearchSanofi

Sanofi sells US drug rights to Covis; Prices bond issue

08-04-2013

Privately held Swiss specialty drug firm Covis Pharma has reached agreement with a USA-based unit of…

Covis PharmaFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalSanofi

Sanofi to invest $75 million in Vietnam facility; views Chinese expansion

03-04-2013

French drug major Sanofi (Euronext: SAN) announced the official launch of a construction project for…

Asia-PacificPharmaceuticalProductionSanofi

Oncodesign in second deal with Sanofi, in the area of tissue protection and repair

27-03-2013

Dijon, France-based Oncodesign, a company specializing in drug discovery and providing pharmacological…

LicensingOncodesignOncologyPharmaceuticalResearchSanofi

Brazil's CAPES joins forces with Sanofi to provide scholarship students with training in research centers abroad

25-03-2013

Brazil's Coordination for the Improvement of Higher Education Personnel (CAPES) and French drug major…

PharmaceuticalResearchSanofiSouth America

Growing US uptake of Genzyme's Aubagio at three months post-launch

07-03-2013

Some 34% of surveyed US neurologists have prescribed French drug major Sanofi (Euronext: SAN) subsidiary…

AubagioBiotechnologyGenzymeMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalSanofi

AAD conference briefs: Celgene's apremilast; and Sanofi's dupilumab

04-03-2013

The European subsidiary of US biotech firm Celgene Corp (Nasdaq: CELG) presented the results from ESTEEM…

apremilastBiotechnologyCelgeneDermatologicalsdupilumabPharmaceuticalRegeneronResearchSanofi

US FDA accepts Sanofi's NDA for diabetes drug lixisenatide

19-02-2013

The US Food and Drug Administration has accepted for review French drug major Sanofi's (Euronext: SAN)…

DiabeteslixisenatideNorth AmericaPharmaceuticalRegulationSanofiZealand Pharma

Genzyme's eliglustat meets endpoints in Ph III studies for Gaucher disease

18-02-2013

US biotech firm Genzyme, a subsidiary if French drug major Sanofi (Euronext: SAN) has released positive…

BiotechnologyeliglustatGenzymePharmaceuticalRare diseasesResearchSanofi

126 to 150 of 304 results

Back to top